Results 131 to 140 of about 66,048 (291)
Hypersensitivity to azathioprine
S. Veraldi, R. Caputo
openaire +2 more sources
ABSTRACT Introduction/Aims Myasthenia gravis (MG) is characterized by fluctuating symptoms, making the assessment of disease activity challenging. Discordance between the clinician‐reported quantitative myasthenia gravis (QMG) score and the patient‐reported MG activity of daily living (MG‐ADL) has previously been observed.
Wanqing Wu+3 more
wiley +1 more source
Trial comparing azathioprine and penicillamine in treatment of rheumatoid arthritis [proceedings]. [PDF]
H Berry+4 more
openalex +1 more source
ABSTRACT First‐line therapeutic approaches for Crohn's disease include immunosuppressants, aminosalicylates, and corticosteroids. However, more than one‐third of patients are resistant to these treatments and require second‐line therapies. Our goal was to synthesize the evidence on the efficacy and safety of biologics and small molecules for inducing ...
Daniela Gorski+5 more
wiley +1 more source
THE EFFECT OF AZATHIOPRINE ON LUPUS GLOMERULONEPHRITIS
John P. Hayslett+3 more
openalex +1 more source
ABSTRACT Underexposure to infliximab often leads to loss of response in patients with inflammatory bowel disease (IBD). Model‐informed precision dosing (MIPD) offers a superior approach to maintaining target infliximab concentrations compared to empirical dosage adjustment.
Yoonjin Kim+3 more
wiley +1 more source
Urticarial Plaques With Vesicles in a Young Hispanic Woman
JEADV Clinical Practice, EarlyView.
Valeria Olvera‐Rodríguez+6 more
wiley +1 more source
Neut‐GI and Re‐Lymp levels correlated with changes in SLEDAl‐2K scores. Specifically, increasing in SLEDAl‐2K scores was associated with decreasing in extended inflammatory parameters. Thus, Neut‐Gland Re‐Lymp might serve as simpler and more cost‐effective alternatives to SLEDAI‐2K scores for monitoring changes in SLE activity.
Galuh Setyorini+5 more
wiley +1 more source